Prediction of diuretic mobilization of cirrhotic ascites by pretreatment fractional sodium excretion
- 1 June 1990
- journal article
- conference paper
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 68 (11) , 545-551
- https://doi.org/10.1007/bf01667146
Abstract
In a randomized prospective study the efficacy and side effects of xipamide versus the combination spironolactone/furosemide in the treatment of cirrhotic ascites were studied. Out of 27 patients four responded to a basic treatment consisting of salt and water restriction and one had to be excluded because of deterioration of kidney function. The remaining 22 patients were randomized to additional treatment with either 20 mg xipamide/day (group I) or 200 mg spironolactone/ day combined with 40 mg of furosemide every other day (group II). A response to treatment during the first 4 days was seen in 7 of 11 patients of group I versus only 3 of 11 patients in group II. In the latter group 7 of 11 patients finally responded after 8 days of treatment. Responsiveness to either diuretic treatment strongly depended on pretreatment fractional Na excretion, FENa. The resistance to diuretic treatment can be predicted by a FENa<0.2%, and could be overcome by additional strategies known to reduce avid proximal Na reabsorption. Xipamide frequently induced hypokalemia, whereas hyperkalemia was seen following treatment with spironolactone/furosemide. Kidney function remained stable during either diuretic treatment.This publication has 16 references indexed in Scilit:
- Saluretic effect of the loop diuretic torasemide in chronic renal failureEuropean Journal of Clinical Pharmacology, 1990
- Pathogenesis of Sodium and Water Retention in High-Output and Low-Output Cardiac Failure, Nephrotic Syndrome, Cirrhosis, and PregnancyNew England Journal of Medicine, 1988
- Influence of cardiac function on the diuretic and hemodynamic effects of the loop diuretic piretanideClinical Cardiology, 1987
- Pharmacodynamics and pharmacokinetics of xipamide in patients with normal and impaired kidney functionEuropean Journal of Clinical Pharmacology, 1984
- Body fluid homeostasis in congestive heart failure and cirrhosis with ascitesThe American Journal of Medicine, 1982
- Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemideEuropean Journal of Clinical Pharmacology, 1981
- Physiologic considerations in the medical management of ascites.1980
- Physiologic Considerations in the Medical Management of AscitesArchives of internal medicine (1960), 1980
- Deranged Sodium Homeostasis in CirrhosisGastroenterology, 1979
- COMPLICATIONS OF DIURETIC THERAPY IN HEPATIC CIRRHOSISThe Lancet, 1966